[HTML][HTML] Association between metabolic syndrome and benign prostatic hyperplasia: The underlying molecular connection

X Fu, Y Wang, Y Lu, J Liu, H Li - Life Sciences, 2024 - Elsevier
Benign prostatic hyperplasia (BPH), a common cause of lower urinary tract symptoms
(LUTS), has been recently regarded as a metabolic disease. Metabolic syndrome (MetS) is a …

Hosta plantaginea (Lam.) Aschers flower modulates inflammation and amino acid metabolism by inhibiting NF-κB/MAPK/JAK-STAT/PI3K-Akt and AMPK pathways to …

H Wang, Z Mu, J Liang, X Li, L Yang, J He - Journal of Ethnopharmacology, 2025 - Elsevier
Ethnopharmacological relevance Benign prostatic hyperplasia (BPH) is the most common
urogenital disease in men with no definitive treatment. Inflammation, androgen imbalance …

Avellanin A Has an Antiproliferative Effect on TP-Induced RWPE-1 Cells via the PI3K-Akt Signalling Pathway

C Xu, G Cao, H Zhang, M Bai, X Yi, X Qu - Marine Drugs, 2024 - mdpi.com
Cyclic pentapeptide compounds have garnered much attention as a drug discovery
resource. This study focused on the characterization and anti-benign prostatic hyperplasia …

The pulmonary protective potential of vanillic acid-loaded TPGS-liposomes: modulation of miR-217/MAPK/NF-κb signalling pathway: “Vanillic acid-loaded TPGS …

NM Sweed, MA Zaafan, MH El-Bishbishy… - Journal of …, 2024 - Taylor & Francis
The aim is to investigate the possible pulmonary protective effect of vanillic acid (VA) in
liposome-TPGS nanoparticles, to overcome VA's poor bioavailability. VA was successfully …

Capsaicin reduces blood glucose and prevents prostate growth by regulating androgen, RAGE/IGF-1/Akt, TGF-β/Smad signalling pathway and reversing epithelial …

H Sun, ZT Wang, BH Tu, ZC Shao, YD Li, D Han… - Naunyn-Schmiedeberg's …, 2024 - Springer
Type 2 diabetes mellitus (T2DM) is a metabolic disease. Diabetes increases the risk of
benign prostatic hyperplasia (BPH). Capsaicin is extracted from chili peppers and …

[HTML][HTML] Mendelian randomization study on simvastatin and gastric cancer: exploring the therapeutic potential of statins in oncology

J Wang, G Cao, Y Liu, S Chen, H Li… - Translational Cancer …, 2024 - pmc.ncbi.nlm.nih.gov
Background Gastric cancer ranks as the fifth most prevalent cancer and the third leading
cause of cancer-related mortality worldwide, Statins, renowned for their cholesterol-lowering …